Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group

Creative Commons License

AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.7, pp.584-598, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 30 Issue: 7
  • Publication Date: 2019
  • Doi Number: 10.5152/tjg.2018.18737
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.584-598
  • Keywords: Gastric cancer, neoadjuvant treatment, adjuvant treatment, staging, surgical treatment, LYMPH-NODE DISSECTION, CLINICAL-PRACTICE GUIDELINES, PHASE-III TRIAL, SIEWERT TYPE-II, PERIOPERATIVE CHEMOTHERAPY, NEOADJUVANT CHEMOTHERAPY, GASTROINTESTINAL CANCER, GASTROESOPHAGEAL ADENOCARCINOMA, PREOPERATIVE CHEMORADIOTHERAPY, PROGNOSTIC-SIGNIFICANCE
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

The geographical location and differences in tumor biology significantly change the management of gastric cancer. The prevalence of gastric cancer ranks fifth and sixth among men and women, respectively, in Turkey. The international guidelines from the Eastern and Western countries fail to manage a considerable amount of inconclusive issues in the management of gastric cancer. The uncertainties lead to significant heterogeneities in clinical practice, lack of homogeneous data collection, and subsequently, diverse outcomes.